From the
Martenson forum, increasing evidence that Ivermectin is another effective tool in the fight against the covid-19 pandemic, both for treatment and prophylaxis.
https://www.trialsitenews.com/zagaz...i-hypothesis-drug-effective-against-covid-19/
This study sought to determine if ivermectin could serve as a prophylactic for those individuals who had been exposed to someone in their household that was tested positive for COVID-19....
The Zagazig University results reveal that out of 203 subjects in the ivermectin arm 15 contacts (7.4%) developed COVID-19 as compared to 59 (58.4%) in the non-intervention arm. Note, all of the subjects were symptomatic based on the study protocol, again here. According to the lead author, the difference between the ivermectin arm and the non-intervention arm was “highly significant” (p<0.001).
https://www.sethbarnes.com/post/iqu...uglmBpqMBfOb74kWdtU-10BJq1hoUFy7MjCeQ5bcCouJo
70% of the people in Iquitos had contracted Covid. Elias Valles is pastor of Remanente Church, the church we worked with. He is a man that I have found trustworthy over two decades of relationship. He reported that "At its peak, the virus was killing 100 people a day." The Guardian's headline was We are Living in a Catastrophe! Indigenous people along the Amazon without health care were especially vulnerable.
In that desperate place, Valles' son, Caleb, decided that something had to be done. He created a group to pray and research options to help.
An amazing discovery
Then a government nurse told him about an amazing discovery. Some of the people who were getting sick were also making extraordinarily quick recoveries. Upon further investigation, they learned that they were taking Ivermectin, a common anti-parasite drug frequently used to help both people and animals fight worms.
Caleb and his friends bought a large supply of Ivermectin. They were able to get it cheaply from veterinarians. They began to distribute it to the poor up and down the river. Their dosage varied according to weight, but averaged about 1.6 mg. Because they didn't have official approval, they kept their efforts quiet. But as word got out that people were being healed, lines began to form to buy Ivermectin. Prices soared.
Eventually thousands of injections of Ivermectin were given. Caleb estimates 15,000 people were treated with a success rate of nearly 100%. He says that a few people suffering from co-morbidities died, but the vast majority were better within a day or two.
https://translate.google.com/translate?hl=&sl=auto&tl=en&u=http://www.pharmabaires.com/1739-resultados-positivos-del-protocolo-iver-car-en-la-profilaxis-de-los-agentes-de-salud.html
The combined use of IOTA-CARRAGENIN AND IVERMECTIN (IVER.CAR PROTOCOL) in the prophylaxis of health agents showed an effectiveness of one hundred percent, among those who received the treatment, the study revealed.
1,195 Health Agents from different Assistance Centers voluntarily participated in the IVER.CAR protocol between June 1 and August 10, distributed in four assistance centers in Ezeiza, Caseros and Cañuelas.
Of the 1,195 Health Agents who participated in the trial, 788 received IVER.CAR, while 407 did not.
In the group that did not receive IVER.CAR, 237 infections (58%) were verified. Conversely, and n the group receiving IVER.CAR, no transmission were recorded.
Here is more information on the IOTA-CARRAGENIN seaweed extract used in this last study:
https://www.news-medical.net/news/2...bits-SARS-CoV-2-in-laboratory-conditions.aspx
In a recent bioRxiv* paper, a research group from the Marinomed Biotech biopharmaceutical company in Austria showed that a sulfated polysaccharide iota-carrageenan has the propensity to inhibit cell entry of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by using an in vitro neutralization assay.
With millions of individuals affected by the coronavirus disease (COVID-19) pandemic, caused by SARS-CoV-2, enormous pressure has been put on the global research community to find an effective drug or vaccine. Thus far, these efforts have been elusive, albeit several promising candidates surfaced recently.
Iota-carrageenan is a sulfated polysaccharide found in certain species of red seaweed (Chondrus crispus) with already well-established antiviral activity against respiratory viruses, which was primarily demonstrated in cell cultures and animal models.
In a nutshell, this polymer seems to stick directly to viruses, hampering in turn viral attachment to host cells. Consequently, a nasal spray containing various concentrations of iota-carrageenan has been developed and already registered as a medical device, with rhinoviruses being a prime target.